Mabvira, S., Khamanga, S. M., & Walker, R. B. (2025). Formulation and characterization of a fixed-dose microemulsion containing efavirenz, emtricitabine, and tenofovir. Pharmaceutical Development & Technology, 30(7), 923. https://doi.org/10.1080/10837450.2025.2537128
Chicago Style (17th ed.) CitationMabvira, Samantha, Sandile M. Khamanga, and Roderick B. Walker. "Formulation and Characterization of a Fixed-dose Microemulsion Containing Efavirenz, Emtricitabine, and Tenofovir." Pharmaceutical Development & Technology 30, no. 7 (2025): 923. https://doi.org/10.1080/10837450.2025.2537128.
MLA (9th ed.) CitationMabvira, Samantha, et al. "Formulation and Characterization of a Fixed-dose Microemulsion Containing Efavirenz, Emtricitabine, and Tenofovir." Pharmaceutical Development & Technology, vol. 30, no. 7, 2025, p. 923, https://doi.org/10.1080/10837450.2025.2537128.